This post is sponsored by MedCity CONVERGE.
Little in medicine evolves faster than precision medicine (even the name keeps moving).
In early September you’ll want to adjust your thinking on the future of genomics one more time.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
MedCity CONVERGE on Sept. 1-2 in Philadelphia features the innovators of precision medicine: from policymakers who can sculpt its evolution to early-stage and established business leaders in the thick of making changes.
Get your ticket for MedCity CONVERGE today.
Precision medicine promises to spark some of CONVERGE’s most compelling and memorable conversations.
Alberto Gutierrez, the director of the FDA’s Office of In Vitro Diagnostics and Radiological Health, kicks off Day 2 of CONVERGE with a keynote address sharing the FDA’s point of view on the future of precision medicine. It was Gutierrez’s signature on the FDA paperwork that brought consumer-driven genomics back from the dead.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Gutierrez will then join a panel led by Forbes contributor David Kroll discussing the challenges and responsibilities of patient empowerment and precision medicine. The panel features:
- Dr. W.H. Wilson Tang, director of the Center for Clinical Genomics at Cleveland Clinic
- Catherine Ball, vice president of genomics and bioinformatics at Ancestry
- Susan Hertzberg, president and CEO at Boston Heart Diagnostics
- Emily Kramer-Golinkoff, the founder of Emily’s Entourage
They won’t be the only doers on the precision medicine front at the conference. The CONVERGE Startup Showcase includes new startups focused on precision medicine. Investors from across healthcare who have examined this issue are also in attendance.
Come to MedCity CONVERGE to fine-tune your thinking on precision medicine – and innovation overall.
